ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

医学 效应器 嵌合抗原受体 细胞因子释放综合征 分级(工程) 细胞因子 免疫系统 免疫学 毒性 内科学 免疫疗法 工程类 土木工程
作者
Daniel W. Lee,Bianca Santomasso,Frederick Lundry Locke,Armin Ghobadi,Cameron John Turtle,Jennifer N. Brudno,Marcela Valderrama Maus,Jae H. Park,Elena Mead,Steven Zivko Pavletic,William Y. Go,Lamis K. Eldjerou,Rebecca Alice Gardner,Noelle V. Frey,Kevin Joseph Curran,Karl S. Peggs,Marcelo C. Pasquini,John F. DiPersio,Marcel R.M. van den Brink,Krishna V. Komanduri
出处
期刊:Biology of Blood and Marrow Transplantation [Elsevier BV]
卷期号:25 (4): 625-638 被引量:3719
标识
DOI:10.1016/j.bbmt.2018.12.758
摘要

Chimeric antigen receptor (CAR) T cell therapy is rapidly emerging as one of the most promising therapies for hematologic malignancies. Two CAR T products were recently approved in the United States and Europe for the treatment ofpatients up to age 25years with relapsed or refractory B cell acute lymphoblastic leukemia and/or adults with large B cell lymphoma. Many more CAR T products, as well as other immunotherapies, including various immune cell- and bi-specific antibody-based approaches that function by activation of immune effector cells, are in clinical development for both hematologic and solid tumor malignancies. These therapies are associated with unique toxicities of cytokine release syndrome (CRS) and neurologic toxicity. The assessment and grading of these toxicities vary considerably across clinical trials and across institutions, making it difficult to compare the safety of different products and hindering the ability to develop optimal strategies for management of these toxicities. Moreover, some aspects of these grading systems can be challenging to implement across centers. Therefore, in an effort to harmonize the definitions and grading systems for CRS and neurotoxicity, experts from all aspects of the field met on June 20 and 21, 2018, at a meeting supported by the American Society for Transplantation and Cellular Therapy (ASTCT; formerly American Society for Blood and Marrow Transplantation, ASBMT) in Arlington, VA. Here we report the consensus recommendations of that group and propose new definitions and grading for CRS and neurotoxicity that are objective, easy to apply, and ultimately more accurately categorize the severity of these toxicities. The goal is to provide a uniform consensus grading system for CRS and neurotoxicity associated with immune effector cell therapies, for use across clinical trials and in the postapproval clinical setting.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
yy完成签到,获得积分10
1秒前
炙热的芙完成签到,获得积分10
1秒前
Dx完成签到 ,获得积分10
1秒前
那你别管完成签到,获得积分10
2秒前
2秒前
完美世界的应助被zbs采纳,获得10
2秒前
zhu完成签到,获得积分10
2秒前
布布爱吃炸鸡完成签到,获得积分10
3秒前
小马猪完成签到,获得积分10
3秒前
lzd完成签到,获得积分10
3秒前
3秒前
郭浩峰完成签到,获得积分10
3秒前
Echo完成签到,获得积分10
4秒前
4秒前
勤奋笙完成签到,获得积分10
5秒前
沄樵完成签到,获得积分10
5秒前
Peter发布了新的文献求助10
6秒前
李xq完成签到,获得积分10
6秒前
于念完成签到 ,获得积分10
6秒前
poi发布了新的文献求助10
6秒前
白马非马完成签到,获得积分10
6秒前
夏侯初完成签到,获得积分10
6秒前
ysymick完成签到,获得积分10
7秒前
大俊哥完成签到,获得积分10
7秒前
Accpted河豚完成签到,获得积分10
7秒前
化学小学生完成签到,获得积分10
8秒前
深情安青的应助被wwwteng呀采纳,获得10
8秒前
小小野发布了新的文献求助10
10秒前
SciGPT的应助被小繁采纳,获得10
11秒前
luyue9406的应助被小马猪采纳,获得20
11秒前
Elanie完成签到,获得积分10
11秒前
ding的应助被byejack采纳,获得10
11秒前
12秒前
神勇萧发布了新的文献求助10
12秒前
赵治猛完成签到,获得积分10
12秒前
Peiqi的应助被Ulrica采纳,获得20
13秒前
自由的雅容完成签到,获得积分10
13秒前
XXXXL完成签到,获得积分10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180189
求助须知:如何正确求助?哪些是违规求助? 9570320
关于积分的说明 21810161
捐赠科研通 7776320
什么是DOI,文献DOI怎么找? 3433267
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039